The United Kingdom has announced on Thursday a ban exporting vital medicines and this will potentially cause or worsen supply problems in Norway.
The UK government restrictions will stop wholesalers selling some medicines meant for UK patients for a higher price in another country. British authorities say their citizens need the medicine themselves.
VG newspaper reported that the drugs affected by the ban are primarily adrenaline pens used for allergy shock. They are sold under the names, EpiPen and Jext. In addition, there is an export ban on rivaroxaban, a blood-thinning agent sold under the name Xarelto in Norway.
According to Today’s Medicine, the UK has banned the export of 24 medicines to other countries.
© #Norway Today
